ENTACAPONE Side Effects

6913533-0 | Agitation, Compulsive Shopping, Depression, Feeling Guilty, Kleptomania, Quality Of Life Decreased, Shoplifting
on Jul 20, 2010 Female patient from ARGENTINA , 68 years of age, was diagnosed with parkinson's disease (What is parkinson's disease?) and was treated with Entacapone (View Usage). Patient experienced the following unwanted or unexpected effects: agitation, compulsive shopping, depression (What is depression?), feeling guilty, kleptomania, quality of life decreased, shoplifting. Entacapone dosage: . During the same period patient was treated with CARBIDOPA AND LEVODOPA (1250 Mg/d) (View Carbidopa And Levodopa Review and Carbidopa And Levodopa Label ), PRAMIPEXOLE DIHYDROCHLORIDE (3 Mg/d) (View Pramipexole Dihydrochloride Review and Pramipexole Dihydrochloride Label ), MIRTAZAPINE (30 Mg/d) (View Mirtazapine Review and Mirtazapine Label ), ROPINIROLE (View Ropinirole Review and Ropinirole Label ), VENLAFAXINE (View Venlafaxine Review and Venlafaxine Label ), RASAGILINE (View Rasagiline Review and Rasagiline Label ), CABERGOLINE (2 Mg/d) (View Cabergoline Review and Cabergoline Label ), LEVODOPA (LEVODOPA) (View Levodopa (levodopa) Review and Levodopa (levodopa) Label ).

6906013-X | Delusion, Feeling Abnormal, Illusion, Persecutory Delusion
Patient was taking Entacapone (View Usage). Patient had the following side effects: delusion, feeling abnormal, illusion, persecutory delusion on Jul 22, 2010 from GREECE Additional patient health information: Male patient , 47 years of age, was diagnosed with parkinson's disease (What is parkinson's disease?) and. Entacapone dosage: Unk. During the same period patient was treated with AMANTADINE HCL (View Amantadine Hcl Review and Amantadine Hcl Label ), LEVODOPA W/BENSERAZIDE/ (500 Mg, Qd) (View Levodopa W/benserazide/ Review and Levodopa W/benserazide/ Label ), PRAMIPEXOLE DIHYDROCHLORIDE (2.1 Mg, Qd) (View Pramipexole Dihydrochloride Review and Pramipexole Dihydrochloride Label ), RASAGILINE (View Rasagiline Review and Rasagiline Label ), ROTIGOTINE (8 Mg, Qd) (View Rotigotine Review and Rotigotine Label ).

6906010-4 | Acute Psychosis, Anxiety, Delusion, Depression, Gait Disturbance, Mobility Decreased, On And Off Phenomenon, Persecutory Delusion, Temporal Arteritis
Adverse event was reported on Jul 22, 2010 by a Female patient taking Entacapone (View Usage) (Dosage: ) was diagnosed with tremor, parkinson's disease (What is parkinson's disease?) and. Location: GREECE , 68 years of age, After Entacapone was administered, patient had the following side effects: acute psychosis, anxiety (What is anxiety?), delusion, depression (What is depression?), gait disturbance, mobility decreased, on and off phenomenon, persecutory delusion, temporal arteritis. During the same period patient was treated with LEVODOPA W/BENSERAZIDE/ (500 Mg, Unk) (View Levodopa W/benserazide/ Review and Levodopa W/benserazide/ Label ), CLONAZEPAM (0.5 Mg Sporadically) (View Clonazepam Review and Clonazepam Label ), ROPINIROLE (0.75 Mg, Qd) (View Ropinirole Review and Ropinirole Label ), OLANZAPINE (7 Mg, Qd) (View Olanzapine Review and Olanzapine Label ). Patient was hospitalized.

6895254-6 | Catatonia, Dyskinesia, Dystonia, Haemorrhage Intracranial, Hypertension, On And Off Phenomenon
on Jul 20, 2010 Female patient from UNITED STATES , 60 years of age, was diagnosed with parkinson's disease (What is parkinson's disease?) and was treated with Entacapone (View Usage). Patient experienced the following unwanted or unexpected effects: catatonia, dyskinesia, dystonia (What is dystonia?), haemorrhage intracranial, hypertension, on and off phenomenon. Entacapone dosage: 800 Mg,. During the same period patient was treated with ROPINIROLE (8 Mg Daily) (View Ropinirole Review and Ropinirole Label ), LEVODOPA (LEVODOPA) (800 Mg) (View Levodopa (levodopa) Review and Levodopa (levodopa) Label ).


6725867-3 | Balance Disorder, Cerebral Atrophy, Hallucination, Visual, Hypersexuality, Parkinson's Disease, Supranuclear Palsy
on May 10, 2010 Male patient from UNITED KINGDOM , 68 years of age, was diagnosed with parkinson's disease (What is parkinson's disease?) and was treated with Entacapone (View Usage). Patient had the following side effects: balance disorder, cerebral atrophy, hallucination, visual, hypersexuality, parkinson's disease (What is parkinson's disease?), supranuclear palsy. Entacapone dosage: 400 Mg Per Day. During the same period patient was treated with L DOPA/CARBIDOPA (300 Mg Per Day Of Levodopa) (View L-dopa/carbidopa Review and L-dopa/carbidopa Label ), L DOPA/CARBIDOPA (700 Mg Per Day Of Levodopa) (View L-dopa/carbidopa Review and L-dopa/carbidopa Label ), L DOPA/CARBIDOPA (1400 Mg Per Day Of Levodopa) (View L-dopa/carbidopa Review and L-dopa/carbidopa Label ), ROPINIROLE (9 Mg Per Day) (View Ropinirole Review and Ropinirole Label ).

6718463-5 | Dyskinesia, Fatigue, Malaise, Motor Dysfunction, Myelofibrosis, Myeloid Metaplasia, On And Off Phenomenon, Parkinson's Disease
Patient was taking Entacapone (View Usage). After Entacapone was administered, patient had the following side effects: dyskinesia, fatigue, malaise, motor dysfunction, myelofibrosis, myeloid metaplasia, on and off phenomenon, parkinson's disease (What is parkinson's disease?) on Feb 22, 2010 from FINLAND Additional patient health information: Male patient , 74 years of age, was diagnosed with parkinson's disease (What is parkinson's disease?), myelofibrosis and. Entacapone dosage: Unk. During the same period patient was treated with THALIDOMIDE (50 Mg, Unk) (View Thalidomide Review and Thalidomide Label ), ROPINIROLE (View Ropinirole Review and Ropinirole Label ), CARBIDOPA LEVODOPA (View Carbidopa-levodopa Review and Carbidopa-levodopa Label ), PREDNISOLONE (50 Mg Daily) (View Prednisolone Review and Prednisolone Label ).

6673036-8 | Dermatillomania, Excoriation, Rash Erythematous
Adverse event was reported on Mar 31, 2010 by a Male patient taking Entacapone (View Usage) (Dosage: 1000 Mg/day) was diagnosed with depression (What is depression?), anxiety (What is anxiety?) and. Location: UNITED STATES , 51 years of age, Patient experienced the following unwanted or unexpected effects: dermatillomania, excoriation, rash erythematous. During the same period patient was treated with LEVODOPA (500 Mg/ Day) (View Levodopa Review and Levodopa Label ), ROPINIROLE (02 Mg/ Day) (View Ropinirole Review and Ropinirole Label ), PAROXETINE HCL (Unk) (View Paroxetine Hcl Review and Paroxetine Hcl Label ), LORAZEPAM (Unk) (View Lorazepam Review and Lorazepam Label ).

6619031-6 | Hyponatraemia, Inappropriate Antidiuretic Hormone Secretion
on Mar 05, 2010 Male patient from JAPAN , 60 years of age, was treated with Entacapone (View Usage). Patient had the following side effects: hyponatraemia, inappropriate antidiuretic hormone secretion. Entacapone dosage: 400 Mg. During the same period patient was treated with PRAMIPEXOLE DIHYDROCHLORIDE (3 Mg) (View Pramipexole Dihydrochloride Review and Pramipexole Dihydrochloride Label ), CARBIDOPA AND LEVODOPA (500 Mg/50 Mg) (View Carbidopa And Levodopa Review and Carbidopa And Levodopa Label ), SELEGILINE HCL (5 Mg) (View Selegiline Hcl Review and Selegiline Hcl Label ), CABERGOLINE (1 Mg) (View Cabergoline Review and Cabergoline Label ), PERGOLIDE (250 Ug) (View Pergolide Review and Pergolide Label ).

6394186-X | Dyskinesia, On And Off Phenomenon
on Sep 26, 2009 Female patient from UNITED STATES , 54 years of age, was diagnosed with parkinsonism and was treated with Entacapone (View Usage). After Entacapone was administered, patient had the following side effects: dyskinesia, on and off phenomenon. Entacapone dosage: . During the same period patient was treated with LEVODOPA (500 Mg/ Day) (View Levodopa Review and Levodopa Label ), PRAMIPEXOLE (View Pramipexole Review and Pramipexole Label ).

6159406-5 | Convulsion, Creatinine Renal Clearance Decreased, Loss Of Consciousness, Renal Artery Stenosis, Renal Impairment
Patient was taking Entacapone (View Usage). Patient experienced the following unwanted or unexpected effects: convulsion, creatinine renal clearance decreased, loss of consciousness, renal artery stenosis, renal impairment on Apr 10, 2009 from UNITED STATES Additional patient health information: Male patient , weighting 160.3 lb, was diagnosed with parkinson's disease (What is parkinson's disease?), hyperlipidaemia, benign prostatic hyperplasia and. Entacapone dosage: 200 Mg, Five Times Daily. During the same period patient was treated with CARBIDOPA + LEVODOPA (25/100 Mg, 1 1/2 Tablets Five Times A Day) (View Carbidopa + Levodopa Review and Carbidopa + Levodopa Label ), AMANTADINE HCL (100 Mg Daily) (View Amantadine Hcl Review and Amantadine Hcl Label ), ROPINIROLE (.25 Mg; 2 Tablets Qam; 1 Tablet Qid) (View Ropinirole Review and Ropinirole Label ), LOVASTATIN (20 Mg With Supper) (View Lovastatin Review and Lovastatin Label ), DOXAZOSIN MESYLATE (1 Mg Qhs) (View Doxazosin Mesylate Review and Doxazosin Mesylate Label ). Patient was hospitalized.

6131812-4 | Alanine Aminotransferase Increased, Aspartate Aminotransferase Increased, Blood Alkaline Phosphatase Increased, Cholestasis, Gamma-glutamyltransferase Increased, Jaundice
Adverse event was reported on Mar 12, 2009 by a Male patient taking Entacapone (View Usage) (Dosage: 1000 Mg Oral) was diagnosed with parkinsonism and. Location: GERMANY , 75 years of age, Patient had the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood alkaline phosphatase increased, cholestasis, gamma-glutamyltransferase increased, jaundice (What is jaundice?). During the same period patient was treated with AMANTADINE HCL (View Amantadine Hcl Review and Amantadine Hcl Label ), LEVODOPA/CARBIDOPA RETADIERT (View Levodopa/carbidopa Retadiert Review and Levodopa/carbidopa Retadiert Label ), LEVODOPA/CARBIDOPA UNRETADIERT (View Levodopa/carbidopa Unretadiert Review and Levodopa/carbidopa Unretadiert Label ).

5944267-7 | Coma, Sudden Onset Of Sleep
on Oct 22, 2008 Male patient from UNITED KINGDOM , 83 years of age, was diagnosed with parkinson's disease (What is parkinson's disease?) and was treated with Entacapone (View Usage). After Entacapone was administered, patient had the following side effects: coma, sudden onset of sleep. Entacapone dosage: 200 Mg/ Bd (at 12 And 16), Oral. During the same period patient was treated with SINEMET (View Sinemet Review and Sinemet Label ), SINEMET CR (View Sinemet Cr Review and Sinemet Cr Label ), TRIMIPRAMINE MALEATE (View Trimipramine Maleate Review and Trimipramine Maleate Label ), FINASTERIDE (View Finasteride Review and Finasteride Label ), TAMSULOSIN MR (View Tamsulosin Mr Review and Tamsulosin Mr Label ), SENNA (View Senna Review and Senna Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), CITALOPRAM HYDROBROMIDE (View Citalopram Hydrobromide Review and Citalopram Hydrobromide Label ). Patient was hospitalized.

5930978-6 | Coma, Sudden Onset Of Sleep
on Oct 09, 2008 Male patient from UNITED KINGDOM , 83 years of age, was diagnosed with parkinson's disease (What is parkinson's disease?) and was treated with Entacapone (View Usage). Patient experienced the following unwanted or unexpected effects: coma, sudden onset of sleep. Entacapone dosage: 200 Mg/ Bd (at 12 And 16). During the same period patient was treated with SINEMET (View Sinemet Review and Sinemet Label ), SINEMET CR (View Sinemet Cr Review and Sinemet Cr Label ), TRIMIPRAMINE MALEATE (View Trimipramine Maleate Review and Trimipramine Maleate Label ), FINASTERIDE (View Finasteride Review and Finasteride Label ), TAMSULOSIN MR (View Tamsulosin Mr Review and Tamsulosin Mr Label ), SENNA (View Senna Review and Senna Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), CITALOPRAM HYDROBROMIDE (View Citalopram Hydrobromide Review and Citalopram Hydrobromide Label ). Patient was hospitalized.

5921354-0 | Abnormal Behaviour, Diarrhoea
Patient was taking Entacapone (View Usage). Patient had the following side effects: abnormal behaviour, diarrhoea on Oct 03, 2008 from UNITED KINGDOM Additional patient health information: Male patient , 78 years of age, . Entacapone dosage: Once Daily Oral, 200mg Bd Oral. During the same period patient was treated with SINEMET (View Sinemet Review and Sinemet Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), SIMVASTATIN (View Simvastatin Review and Simvastatin Label ), PERSANTIN MR (View Persantin Mr Review and Persantin Mr Label ), GLICLAZIDE (View Gliclazide Review and Gliclazide Label ), METFORMIN HYDROCHLORIDE (View Metformin Hydrochloride Review and Metformin Hydrochloride Label ). Patient was hospitalized.

5901292-X | Abnormal Behaviour, Diarrhoea
Adverse event was reported on Sep 15, 2008 by a Male patient taking Entacapone (View Usage) (Dosage: Once Daily, Oral) was diagnosed with ill-defined disorder and. Location: UNITED KINGDOM , 78 years of age, After Entacapone was administered, patient had the following side effects: abnormal behaviour, diarrhoea. During the same period patient was treated with SINEMT 110 (View Sinemt 110 Review and Sinemt 110 Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), SIMVASTATIN (View Simvastatin Review and Simvastatin Label ), PERSANTIN MR (View Persantin Mr Review and Persantin Mr Label ), GLICLAZIDE (View Gliclazide Review and Gliclazide Label ). Patient was hospitalized.

5877379-7 | Aggression, Confusional State, Psychotic Disorder
on Aug 27, 2008 Male patient from GERMANY , 79 years of age, was diagnosed with dementia (What is dementia?), parkinson's disease (What is parkinson's disease?) and was treated with Entacapone (View Usage). Patient experienced the following unwanted or unexpected effects: aggression, confusional state, psychotic disorder (What is psychotic disorder?). Entacapone dosage: 4 Dosages Daily Oral. During the same period patient was treated with EXELON (4.6 Mg/24 H Patch; 9.5 Mg/24 H Patch Transdermal) (View Exelon Review and Exelon Label ), LEVOPAR 125 (4 Dosages Oral) (View Levopar 125 Review and Levopar 125 Label ), SEROQUEL (View Seroquel Review and Seroquel Label ), ESCITALOPRAM (View Escitalopram Review and Escitalopram Label ). Patient was hospitalized.

5877378-5 | Akinesia, Coma, Sudden Onset Of Sleep, Unresponsive To Stimuli
on Aug 22, 2008 Male patient from UNITED KINGDOM , 83 years of age, was diagnosed with parkinson's disease (What is parkinson's disease?) and was treated with Entacapone (View Usage). Patient had the following side effects: akinesia, coma, sudden onset of sleep, unresponsive to stimuli. Entacapone dosage: 200 Mg/ Bd Oral. During the same period patient was treated with SINEMET (View Sinemet Review and Sinemet Label ). Patient was hospitalized.

5771440-3 | Affect Lability, Amnesia, Condition Aggravated, Confusional State, Delirium, Failure To Thrive, Fatigue, Gait Disturbance, Hallucination
Patient was taking Entacapone (View Usage). After Entacapone was administered, patient had the following side effects: affect lability, amnesia, condition aggravated, confusional state, delirium, failure to thrive, fatigue, gait disturbance, hallucination on May 26, 2008 from UNITED STATES Additional patient health information: Female patient , 85 years of age, was diagnosed with tremor, atrial fibrillation (What is atrial fibrillation?) and. Entacapone dosage: . During the same period patient was treated with AMIODARONE HCL (View Amiodarone Hcl Review and Amiodarone Hcl Label ), ALPRAZOLAM (View Alprazolam Review and Alprazolam Label ), CYPROHEPTADINE HCL (View Cyproheptadine Hcl Review and Cyproheptadine Hcl Label ), CARBIDOPA AND LEVODOPA (View Carbidopa And Levodopa Review and Carbidopa And Levodopa Label ).

5732468-2 | Cardiopulmonary Failure, Delusion, Dyspnoea, Hallucination, Hypotension, Muscle Rigidity, Psychotic Disorder
Adverse event was reported on Apr 21, 2008 by a Male patient taking Entacapone (View Usage) (Dosage: 200 Mg, Oral) was diagnosed with parkinson's disease (What is parkinson's disease?) and. Location: POLAND , 57 years of age, Patient experienced the following unwanted or unexpected effects: cardiopulmonary failure, delusion, dyspnoea, hallucination, hypotension, muscle rigidity, psychotic disorder (What is psychotic disorder?). During the same period patient was treated with LEVODOPA (View Levodopa Review and Levodopa Label ), TRIHEXYLPHENIDYL (View Trihexylphenidyl Review and Trihexylphenidyl Label ), ZOPICLONE (View Zopiclone Review and Zopiclone Label ), CLONAZEPAM (View Clonazepam Review and Clonazepam Label ), PERINDOPRIL ERBUMINE (View Perindopril Erbumine Review and Perindopril Erbumine Label ). Patient was hospitalized.

5708756-2 | Aggression, Confusional State, Psychotic Disorder
on Mar 28, 2008 Male patient from GERMANY , 79 years of age, was diagnosed with dementia (What is dementia?), parkinson's disease (What is parkinson's disease?) and was treated with Entacapone (View Usage). Patient had the following side effects: aggression, confusional state, psychotic disorder (What is psychotic disorder?). Entacapone dosage: 4 Dosages Daily Oral. During the same period patient was treated with EXELON (9.5 Mg/24 H Patch Transdermal) (View Exelon Review and Exelon Label ), LEVOPAR 125 (4 Dosages Oral) (View Levopar 125 Review and Levopar 125 Label ), SEROQUEL (View Seroquel Review and Seroquel Label ), ESCITALOPRAM (View Escitalopram Review and Escitalopram Label ). Patient was hospitalized.

5671126-X | Basal Ganglia Haemorrhage, Muscle Rigidity, Visual Field Defect
on Feb 24, 2008 Male patient from UNITED STATES , 77 years of age, weighting 209.4 lb, was diagnosed with parkinson's disease (What is parkinson's disease?) and was treated with Entacapone (View Usage). After Entacapone was administered, patient had the following side effects: basal ganglia haemorrhage, muscle rigidity, visual field defect. Entacapone dosage: 200 Mg Qid. During the same period patient was treated with CARBIDOPA + LEVODOPA (25/100mg, 1,5 Df X4, Oral; 25/250mg X 4, Oral) (View Carbidopa + Levodopa Review and Carbidopa + Levodopa Label ), PRAMIPEXOLE DIHYDROCHLORIDE (1,5 Mg Tid) (View Pramipexole Dihydrochloride Review and Pramipexole Dihydrochloride Label ), PROSOURCE (View Prosource Review and Prosource Label ), NUTREN (View Nutren Review and Nutren Label ). Patient was hospitalized.

5670521-2 | Cardiac Arrest, Concomitant Disease Progression, Dysphagia, Insomnia, Metastases To Lymph Nodes, Oesophageal Carcinoma, Oesophageal Stenosis, Oral Intake Reduced, Respiratory Arrest
Patient was taking Entacapone (View Usage). Patient experienced the following unwanted or unexpected effects: cardiac arrest (What is cardiac arrest?), concomitant disease progression, dysphagia, insomnia, metastases to lymph nodes, oesophageal carcinoma, oesophageal stenosis, oral intake reduced, respiratory arrest on Mar 13, 2008 from JAPAN Additional patient health information: Male patient , 74 years of age, weighting 101.4 lb, was diagnosed with parkinson's disease (What is parkinson's disease?), gastric ulcer, dyspepsia, constipation (What is constipation?) and. Entacapone dosage: 200mg Qid (800mg/day). During the same period patient was treated with FAMOTIDINE (View Famotidine Review and Famotidine Label ), SEVEN EP (View Seven Ep Review and Seven Ep Label ), MUCOSTA (View Mucosta Review and Mucosta Label ), EC DOPARL (View Ec Doparl Review and Ec Doparl Label ), MAGNESIUM OXIDE (View Magnesium Oxide Review and Magnesium Oxide Label ), LECICARBON (View Lecicarbon Review and Lecicarbon Label ). Patient was hospitalized.

5635958-6 | Feeding Tube Complication, Gastrostomy Tube Insertion, Muscle Rigidity, Tracheostomy, Tremor, Visual Field Defect
Adverse event was reported on Feb 14, 2008 by a Male patient taking Entacapone (View Usage) (Dosage: 200 Mg, Qid) was diagnosed with parkinson's disease (What is parkinson's disease?) and. Location: UNITED STATES , 77 years of age, weighting 209.4 lb, Patient had the following side effects: feeding tube complication, gastrostomy tube insertion, muscle rigidity, tracheostomy, tremor, visual field defect. During the same period patient was treated with CARBIDOPA + LEVODOPA (25mg/100 Mg, 1.5 Df Four Times/d) (View Carbidopa + Levodopa Review and Carbidopa + Levodopa Label ), PRAMIPEXOLE DIHYDROCHLORIDE (1.5 Mg, Tid) (View Pramipexole Dihydrochloride Review and Pramipexole Dihydrochloride Label ), NUTREN (View Nutren Review and Nutren Label ), PROSOURCE (View Prosource Review and Prosource Label ). Patient was hospitalized.

5632293-7 | Hallucination, Visual
on Jan 08, 2008 Male patient from FINLAND , 69 years of age, was diagnosed with parkinson's disease (What is parkinson's disease?), onychomycosis and was treated with Entacapone (View Usage). After Entacapone was administered, patient had the following side effects: hallucination, visual. Entacapone dosage: 800 Mg. During the same period patient was treated with LAMISIL (250 Mg) (View Lamisil Review and Lamisil Label ), SINEMET (400 Mg) (View Sinemet Review and Sinemet Label ), REQUIP (21 Mg) (View Requip Review and Requip Label ), MAREVAN (View Marevan Review and Marevan Label ), NITROGLYCERIN (View Nitroglycerin Review and Nitroglycerin Label ), VERRUXIN (View Verruxin Review and Verruxin Label ).

5607728-6 | Hallucination, Visual
on Jan 08, 2008 Male patient from FINLAND , 69 years of age, was diagnosed with parkinson's disease (What is parkinson's disease?) and was treated with Entacapone (View Usage). Patient experienced the following unwanted or unexpected effects: hallucination, visual. Entacapone dosage: 800 Mg, Oral. During the same period patient was treated with MAREVAN (View Marevan Review and Marevan Label ), NITROGLYCERIN (View Nitroglycerin Review and Nitroglycerin Label ), VERRUXIN (View Verruxin Review and Verruxin Label ).

5590605-7 | Abnormal Behaviour, Asthenia, Diarrhoea, Viral Infection, Weight Decreased
Patient was taking Entacapone (View Usage). Patient had the following side effects: abnormal behaviour, asthenia, diarrhoea, viral infection (What is viral infection?), weight decreased on Dec 22, 2007 from UNITED STATES Additional patient health information: Male patient , 83 years of age, weighting 157.0 lb, was diagnosed with parkinson's disease (What is parkinson's disease?) and. Entacapone dosage: 800 Mg, 4 In 1 D. Patient was hospitalized.

5589322-9 | Dental Caries, Dry Mouth, Gingival Recession, Mineral Deficiency, Prostate Cancer, Tooth Loss
Adverse event was reported on Dec 21, 2007 by a Male patient taking Entacapone (View Usage) (Dosage: 800 Mg (200 Mg, 4 In 1 D)) was diagnosed with parkinson's disease (What is parkinson's disease?) and. Location: UNITED KINGDOM , 65 years of age, After Entacapone was administered, patient had the following side effects: dental caries, dry mouth, gingival recession, mineral deficiency, prostate cancer (What is prostate cancer?), tooth loss. During the same period patient was treated with SINEMET (View Sinemet Review and Sinemet Label ), SELEGILINE HCL (View Selegiline Hcl Review and Selegiline Hcl Label ), ROPINIROLE HCL (View Ropinirole Hcl Review and Ropinirole Hcl Label ).

5557973-3 | Pneumonia
on Nov 28, 2007 Male patient from UNITED KINGDOM , 52 years of age, was diagnosed with parkinson's disease (What is parkinson's disease?) and was treated with Entacapone (View Usage). Patient experienced the following unwanted or unexpected effects: pneumonia (What is pneumonia?). Entacapone dosage: 1 Tablet, 5x Daily, Oral. During the same period patient was treated with CO CARELDOPA (View Co-careldopa Review and Co-careldopa Label ), TEGRETAL RETARD (View Tegretal Retard Review and Tegretal Retard Label ), LIPRINEL CAP (View Liprinel Cap Review and Liprinel Cap Label ). Patient was hospitalized.

5528060-5 | Dry Mouth, Prostate Cancer, Tooth Loss
on Oct 31, 2007 Male patient from UNITED KINGDOM , 65 years of age, was diagnosed with parkinson's disease (What is parkinson's disease?) and was treated with Entacapone (View Usage). Patient had the following side effects: dry mouth, prostate cancer (What is prostate cancer?), tooth loss. Entacapone dosage: 800 Mg (200 Mg, 4 In 1 D) Oral. During the same period patient was treated with SINEMET (View Sinemet Review and Sinemet Label ), SELEGILINE HCL (View Selegiline Hcl Review and Selegiline Hcl Label ), ROPINIROLE HCL (View Ropinirole Hcl Review and Ropinirole Hcl Label ).

5503621-8 | Dental Caries, Prostate Cancer, Tooth Decalcification, Tooth Loss
Patient was taking Entacapone (View Usage). After Entacapone was administered, patient had the following side effects: dental caries, prostate cancer (What is prostate cancer?), tooth decalcification, tooth loss on Oct 15, 2007 from UNITED KINGDOM Additional patient health information: Male patient , 65 years of age, was diagnosed with parkinson's disease (What is parkinson's disease?) and. Entacapone dosage: 800 Mg (200 Mg, 4 In 1 D) Oral. During the same period patient was treated with SINEMET (View Sinemet Review and Sinemet Label ), SELEGILINE HCL (View Selegiline Hcl Review and Selegiline Hcl Label ), ROPINIROLE HCL (View Ropinirole Hcl Review and Ropinirole Hcl Label ).

5503618-8 | Colitis
Adverse event was reported on Oct 15, 2007 by a Female patient taking Entacapone (View Usage) (Dosage: 600 Mg, 1-1-1) was diagnosed with parkinson's disease (What is parkinson's disease?) and. Location: GERMANY , 50 years of age, Patient experienced the following unwanted or unexpected effects: colitis. During the same period patient was treated with RUNOTIV (View Runotiv Review and Runotiv Label ), AMANTADINE HCL (View Amantadine Hcl Review and Amantadine Hcl Label ), SIFROL (View Sifrol Review and Sifrol Label ), MADOPAR (View Madopar Review and Madopar Label ). Patient was hospitalized.

5503486-4 | Hallucination, Visual, Nail Tinea
on Oct 10, 2007 Male patient from FINLAND , 69 years of age, was diagnosed with parkinson's disease (What is parkinson's disease?), nail tinea and was treated with Entacapone (View Usage). Patient had the following side effects: hallucination, visual, nail tinea. Entacapone dosage: 800 Mg. During the same period patient was treated with LAMISIL (205 Mg Oral) (View Lamisil Review and Lamisil Label ), SINEMET (400 Mg) (View Sinemet Review and Sinemet Label ), REQUIP (21 Mg) (View Requip Review and Requip Label ), MAREVAN (View Marevan Review and Marevan Label ), NITROGLYCERIN (View Nitroglycerin Review and Nitroglycerin Label ), VERUXIN (View Veruxin Review and Veruxin Label ).

5501531-3 | Cardiac Arrest, Concomitant Disease Progression, Dysphagia, Metastases To Lymph Nodes, Oesophageal Carcinoma, Oesophageal Stenosis, Oral Intake Reduced, Respiratory Arrest, Sputum Retention
on Oct 23, 2007 Male patient from JAPAN , 74 years of age, weighting 101.4 lb, was diagnosed with parkinson's disease (What is parkinson's disease?), gastric ulcer, dyspepsia, constipation (What is constipation?), haemorrhoids and was treated with Entacapone (View Usage). After Entacapone was administered, patient had the following side effects: cardiac arrest (What is cardiac arrest?), concomitant disease progression, dysphagia, metastases to lymph nodes, oesophageal carcinoma, oesophageal stenosis, oral intake reduced, respiratory arrest, sputum retention. Entacapone dosage: 200mg Qid (800mg/day). During the same period patient was treated with FAMOTIDINE (View Famotidine Review and Famotidine Label ), SEVEN EP (View Seven Ep Review and Seven Ep Label ), MUCOSTA (View Mucosta Review and Mucosta Label ), EC DOPARL (View Ec Doparl Review and Ec Doparl Label ), MAGNESIUM OXIDE (View Magnesium Oxide Review and Magnesium Oxide Label ), LECICARBON (View Lecicarbon Review and Lecicarbon Label ), POSTERISAN (View Posterisan Review and Posterisan Label ). Patient was hospitalized.

5493508-1 | Faeces Discoloured
Patient was taking Entacapone (View Usage). Patient experienced the following unwanted or unexpected effects: faeces discoloured on Oct 01, 2007 from UNITED KINGDOM Additional patient health information: Male patient , 78 years of age, was diagnosed with parkinson's disease (What is parkinson's disease?) and. Entacapone dosage: 2 Df 1/1 Days. During the same period patient was treated with SINEMET (View Sinemet Review and Sinemet Label ), CITALOPRAM HYDROBROMIDE (View Citalopram Hydrobromide Review and Citalopram Hydrobromide Label ), QUETIAPINE FUMARATE (View Quetiapine Fumarate Review and Quetiapine Fumarate Label ), GLICLAZIDE (View Gliclazide Review and Gliclazide Label ), ACETAMINOPHEN (View Acetaminophen Review and Acetaminophen Label ). Patient was hospitalized.

5488311-2 | Cardiac Arrest, Concomitant Disease Progression, Dysphagia, Metastases To Lymph Nodes, Oesophageal Carcinoma, Oesophageal Stenosis, Oral Intake Reduced, Respiratory Arrest, Sputum Retention
Adverse event was reported on Sep 19, 2007 by a Male patient taking Entacapone (View Usage) (Dosage: 200mg Qid (800mg/day)) was diagnosed with parkinson's disease (What is parkinson's disease?), gastric ulcer, dyspepsia, constipation (What is constipation?), haemorrhoids and. Location: JAPAN , 74 years of age, weighting 101.4 lb, Patient had the following side effects: cardiac arrest (What is cardiac arrest?), concomitant disease progression, dysphagia, metastases to lymph nodes, oesophageal carcinoma, oesophageal stenosis, oral intake reduced, respiratory arrest, sputum retention. During the same period patient was treated with FAMOTIDINE (View Famotidine Review and Famotidine Label ), SEVEN EP (View Seven Ep Review and Seven Ep Label ), MUCOSTA (View Mucosta Review and Mucosta Label ), EC DOPARL (View Ec Doparl Review and Ec Doparl Label ), MAGNESIUM OXIDE (View Magnesium Oxide Review and Magnesium Oxide Label ), LECICARBON (View Lecicarbon Review and Lecicarbon Label ), POSTERISAN (View Posterisan Review and Posterisan Label ). Patient was hospitalized.

5484367-1 | Cardiopulmonary Failure, Cardiovascular Insufficiency, Delusion, Hallucination, Muscle Rigidity, Psychotic Disorder, Shock
on Sep 17, 2007 Male patient from POLAND , 57 years of age, was diagnosed with parkinson's disease (What is parkinson's disease?) and was treated with Entacapone (View Usage). After Entacapone was administered, patient had the following side effects: cardiopulmonary failure, cardiovascular insufficiency, delusion, hallucination, muscle rigidity, psychotic disorder (What is psychotic disorder?), shock. Entacapone dosage: 200 Mg Oral. During the same period patient was treated with LEVODOPA (View Levodopa Review and Levodopa Label ), TRIHEXYLPHENIDYL (View Trihexylphenidyl Review and Trihexylphenidyl Label ), ZOPICLONE (View Zopiclone Review and Zopiclone Label ), CLONAZEPAM (View Clonazepam Review and Clonazepam Label ), PERINDOPRIL ERBUMINE (View Perindopril Erbumine Review and Perindopril Erbumine Label ). Patient was hospitalized.

5483893-9 | Contusion, International Normalised Ratio Increased, Rectal Haemorrhage
on Sep 24, 2007 Male patient from UNITED KINGDOM , 84 years of age, was diagnosed with parkinson's disease (What is parkinson's disease?) and was treated with Entacapone (View Usage). Patient experienced the following unwanted or unexpected effects: contusion, international normalised ratio increased, rectal haemorrhage. Entacapone dosage: 200 Mg; Oral, 400 Mg (200mg, 2 In 1 D); Oral, 600 Mg (200mg, 3 In 1 D) Oral,. During the same period patient was treated with WARFARIN SODIUM (Various Dose;) (View Warfarin Sodium Review and Warfarin Sodium Label ), MADOPAR (View Madopar Review and Madopar Label ), QUININE SULFATE (View Quinine Sulfate Review and Quinine Sulfate Label ), RAMIPRIL (View Ramipril Review and Ramipril Label ), FALODIPINE MR (View Falodipine Mr Review and Falodipine Mr Label ), AMIODARONE HYDROCHLORIDE (View Amiodarone Hydrochloride Review and Amiodarone Hydrochloride Label ). Patient was hospitalized and became disabled.

5442570-0 | Arthralgia, Asthma, Back Pain, Contusion, Neck Pain, Pneumonia
Patient was taking Entacapone (View Usage). Patient had the following side effects: arthralgia, asthma (What is asthma?), back pain (What is back pain?), contusion, neck pain, pneumonia (What is pneumonia?) on Aug 16, 2007 from UNITED STATES Additional patient health information: Female patient , weighting 105.0 lb, . Entacapone dosage: Oral. During the same period patient was treated with MIRAPEX (View Mirapex Review and Mirapex Label ).

5441719-3 | Hallucination, Visual
Adverse event was reported on Aug 08, 2007 by a Male patient taking Entacapone (View Usage) (Dosage: 800 Mg) was diagnosed with parkinson's disease (What is parkinson's disease?), nail tinea and. Location: FINLAND , 69 years of age, After Entacapone was administered, patient had the following side effects: hallucination, visual. During the same period patient was treated with LAMISIL (205 Mg Oral) (View Lamisil Review and Lamisil Label ), SINEMET (400 Mg) (View Sinemet Review and Sinemet Label ), REQUIP (21 Mg) (View Requip Review and Requip Label ), MAREVAN (View Marevan Review and Marevan Label ), NITROGLYCERIN (View Nitroglycerin Review and Nitroglycerin Label ), VERRUXIN (View Verruxin Review and Verruxin Label ).

5244062-0 | Hallucination, Lumbar Spinal Stenosis, Neuralgia, Spinal Operation
on Feb 07, 2007 Male patient from UNITED KINGDOM , 75 years of age, was diagnosed with parkinson's disease (What is parkinson's disease?), neuralgia and was treated with Entacapone (View Usage). Patient experienced the following unwanted or unexpected effects: hallucination, lumbar spinal stenosis, neuralgia, spinal operation. Entacapone dosage: 200 Mg, 5qd. During the same period patient was treated with GABAPENTIN (200 Mg, Tid) (View Gabapentin Review and Gabapentin Label ), CARBIDOPA AND LEVODOPA (100/25 Mg X5/day) (View Carbidopa And Levodopa Review and Carbidopa And Levodopa Label ). Patient was hospitalized.

5141924-X | Condition Aggravated, Deep Brain Stimulation, Dyskinesia, Haemorrhage, Inguinal Hernia, Inguinal Hernia Repair, Parkinson's Disease, Post Procedural Haematoma, Pyrexia
on Jan 05, 2004 Male patient from JAPAN , 55 years of age, weighting 121.9 lb, was diagnosed with parkinson's disease (What is parkinson's disease?) and was treated with Entacapone (View Usage). Patient had the following side effects: condition aggravated, deep brain stimulation, dyskinesia, haemorrhage, inguinal hernia, inguinal hernia repair, parkinson's disease (What is parkinson's disease?), post procedural haematoma, pyrexia. Entacapone dosage: 700 Mg. Patient was hospitalized.

5131551-2 | Abdominal Distension, Abdominal Pain, Abnormal Faeces, Acute Respiratory Distress Syndrome, Anorexia, Ascites, Blood Glucose Decreased, Bradycardia, Bundle Branch Block Right
Patient was taking Entacapone (View Usage). After Entacapone was administered, patient had the following side effects: abdominal distension, abdominal pain (What is abdominal pain?), abnormal faeces, acute respiratory distress syndrome, anorexia, ascites, blood glucose decreased, bradycardia, bundle branch block right on Jun 28, 2006 from JAPAN Additional patient health information: Male patient , 71 years of age, weighting 110.2 lb, was diagnosed with parkinson's disease (What is parkinson's disease?) and. Entacapone dosage: 1200mg. During the same period patient was treated with MADOPAR (View Madopar Review and Madopar Label ), DEPAS (View Depas Review and Depas Label ), GASMOTIN (View Gasmotin Review and Gasmotin Label ), SYMMETREL (View Symmetrel Review and Symmetrel Label ). Patient was hospitalized.

5126117-4 | Dysphonia, Libido Increased, Movement Disorder, Restlessness
Adverse event was reported on Jul 12, 2006 by a Male patient taking Entacapone (View Usage) (Dosage: 800 Mg, Unk) was diagnosed with parkinson's disease (What is parkinson's disease?), back pain (What is back pain?), gastritis, hypoaesthesia and. Location: JAPAN , 66 years of age, weighting 169.8 lb, Patient experienced the following unwanted or unexpected effects: dysphonia, libido increased, movement disorder (What is movement disorder?), restlessness. During the same period patient was treated with NEODOPASOL (1000 Mg, Unk) (View Neodopasol Review and Neodopasol Label ), FP (View Fp Review and Fp Label ), PARLODEL (View Parlodel Review and Parlodel Label ), YODEL S (View Yodel S Review and Yodel S Label ), LOXONIN (View Loxonin Review and Loxonin Label ), MUCOSTA (View Mucosta Review and Mucosta Label ), CYANOCOBALAMIN (View Cyanocobalamin Review and Cyanocobalamin Label ). Patient was hospitalized.

5115181-4 | Abdominal Distension, Abdominal Pain, Abnormal Faeces, Acute Respiratory Distress Syndrome, Anorexia, Ascites, Blood Glucose Decreased, Bradycardia, Bundle Branch Block Right
on Jun 28, 2006 Male patient from JAPAN , 71 years of age, weighting 110.2 lb, was diagnosed with parkinson's disease (What is parkinson's disease?) and was treated with Entacapone (View Usage). Patient had the following side effects: abdominal distension, abdominal pain (What is abdominal pain?), abnormal faeces, acute respiratory distress syndrome, anorexia, ascites, blood glucose decreased, bradycardia, bundle branch block right. Entacapone dosage: 1200mg. During the same period patient was treated with MADOPAR (View Madopar Review and Madopar Label ), DEPAS (View Depas Review and Depas Label ), GASMOTIN (View Gasmotin Review and Gasmotin Label ), SYMMETREL (View Symmetrel Review and Symmetrel Label ). Patient was hospitalized.

5095447-7 | Condition Aggravated, Deep Brain Stimulation, Dyskinesia, Haemorrhage, Inguinal Hernia, Inguinal Hernia Repair, Parkinson's Disease, Post Procedural Haematoma, Pyrexia
on Jan 05, 2004 Male patient from JAPAN , 55 years of age, weighting 121.9 lb, was diagnosed with parkinson's disease (What is parkinson's disease?) and was treated with Entacapone (View Usage). After Entacapone was administered, patient had the following side effects: condition aggravated, deep brain stimulation, dyskinesia, haemorrhage, inguinal hernia, inguinal hernia repair, parkinson's disease (What is parkinson's disease?), post procedural haematoma, pyrexia. Entacapone dosage: 700 Mg. Patient was hospitalized.

5086824-9 | Abdominal Distension, Abdominal Pain, Abnormal Faeces, Acute Respiratory Distress Syndrome, Anorexia, Ascites, Blood Glucose Decreased, Bundle Branch Block Right, Chest Pain
Patient was taking Entacapone (View Usage). Patient experienced the following unwanted or unexpected effects: abdominal distension, abdominal pain (What is abdominal pain?), abnormal faeces, acute respiratory distress syndrome, anorexia, ascites, blood glucose decreased, bundle branch block right, chest pain (What is chest pain?) on Jun 28, 2006 from JAPAN Additional patient health information: Male patient , 71 years of age, weighting 110.2 lb, was diagnosed with parkinson's disease (What is parkinson's disease?) and. Entacapone dosage: 1200mg. During the same period patient was treated with MADOPAR (View Madopar Review and Madopar Label ), DEPAS (View Depas Review and Depas Label ), GASMOTIN (View Gasmotin Review and Gasmotin Label ), SYMMETREL (View Symmetrel Review and Symmetrel Label ), DOPS (View Dops Review and Dops Label ), AMOBAN (View Amoban Review and Amoban Label ), BASEN (View Basen Review and Basen Label ). Patient was hospitalized.

5086823-7 | Abdominal Distension, Abdominal Pain, Abnormal Faeces, Anorexia, Ascites, Blood Glucose Decreased, Bundle Branch Block Right, Chest Pain, Chills
Adverse event was reported on Jun 28, 2006 by a Male patient taking Entacapone (View Usage) (Dosage: 1200mg) was diagnosed with parkinson's disease (What is parkinson's disease?) and. Location: JAPAN , 71 years of age, weighting 110.2 lb, Patient had the following side effects: abdominal distension, abdominal pain (What is abdominal pain?), abnormal faeces, anorexia, ascites, blood glucose decreased, bundle branch block right, chest pain (What is chest pain?), chills. During the same period patient was treated with MADOPAR (View Madopar Review and Madopar Label ), DEPAS (View Depas Review and Depas Label ), GASMOTIN (View Gasmotin Review and Gasmotin Label ), SYMMETREL (View Symmetrel Review and Symmetrel Label ), DOPS (View Dops Review and Dops Label ), AMOBAN (View Amoban Review and Amoban Label ), BASEN (View Basen Review and Basen Label ). Patient was hospitalized.

5065561-0 | Dysphonia, Libido Increased, Movement Disorder, Restlessness
on Jul 12, 2006 Male patient from JAPAN , 66 years of age, weighting 169.8 lb, was diagnosed with parkinson's disease (What is parkinson's disease?), back pain (What is back pain?), gastritis, hypoaesthesia and was treated with Entacapone (View Usage). After Entacapone was administered, patient had the following side effects: dysphonia, libido increased, movement disorder (What is movement disorder?), restlessness. Entacapone dosage: 800 Mg, Unk. During the same period patient was treated with NEODOPASOL (1000 Mg, Unk) (View Neodopasol Review and Neodopasol Label ), FP (View Fp Review and Fp Label ), PARLODEL (View Parlodel Review and Parlodel Label ), YODEL S (View Yodel S Review and Yodel S Label ), LOXONIN (View Loxonin Review and Loxonin Label ), MUCOSTA (View Mucosta Review and Mucosta Label ), CYANOCOBALAMIN (View Cyanocobalamin Review and Cyanocobalamin Label ). Patient was hospitalized.

5058329-2 | Libido Increased, Restlessness
on Jul 12, 2006 Male patient from JAPAN , weighting 169.8 lb, was diagnosed with parkinson's disease (What is parkinson's disease?), back pain (What is back pain?), gastritis, hypoaesthesia and was treated with Entacapone (View Usage). Patient experienced the following unwanted or unexpected effects: libido increased, restlessness. Entacapone dosage: 800 Mg, Unk. During the same period patient was treated with NEODOPASOL (1000 Mg, Unk) (View Neodopasol Review and Neodopasol Label ), FP (View Fp Review and Fp Label ), PARLODEL (View Parlodel Review and Parlodel Label ), YODEL S (View Yodel S Review and Yodel S Label ), LOXONIN (View Loxonin Review and Loxonin Label ), MUCOSTA (View Mucosta Review and Mucosta Label ), CYANOCOBALAMIN (View Cyanocobalamin Review and Cyanocobalamin Label ), OPALMON (View Opalmon Review and Opalmon Label ). Patient was hospitalized.

4959102-3 | Activities Of Daily Living Impaired, Blood Pressure Increased, Coma, Confusional State, Depressed Level Of Consciousness, Fall, Heat Rash, Oral Intake Reduced, Pupillary Light Reflex Tests Abnormal
Patient was taking Entacapone (View Usage). Patient had the following side effects: activities of daily living impaired, blood pressure increased, coma, confusional state, depressed level of consciousness, fall (What is fall?), heat rash, oral intake reduced, pupillary light reflex tests abnormal on Feb 27, 2006 from Additional patient health information: Male patient , 71 years of age, weighting 110.2 lb, was diagnosed with parkinson's disease (What is parkinson's disease?), anxiety (What is anxiety?), anxiety disorder, constipation (What is constipation?) and. Entacapone dosage: 1200 Mg, Unk. During the same period patient was treated with MADOPAR (View Madopar Review and Madopar Label ), SYMMETREL (View Symmetrel Review and Symmetrel Label ), DOPS (View Dops Review and Dops Label ), CABASER (View Cabaser Review and Cabaser Label ), DOMIN (View Domin Review and Domin Label ), DEPAS (View Depas Review and Depas Label ), ANAFRANIL (View Anafranil Review and Anafranil Label ), GASMOTIN (View Gasmotin Review and Gasmotin Label ). Patient was hospitalized.